AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
Hours of analysis helped us find that the best trading platforms offer low margin rates, fast execution, a large selection of research and investments, low costs and a robust mobile app. NerdWallet is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results